I am pretty confident that NP would have to disclose an material information. And I don't think he would get a pass because of any relation to what the FDA might or might not be doing.

I think the only way that he could get out of the disclosure was if the analysis could be determined as "incomplete" by a "reasonable person" in a court of law.

Therefore, I think we have a few options:
1) The data took longer to lock than anticipated. (For whatever reason; perhaps because they decided to collect data to Day 42).

2) AMAREX has the data and is working through the analysis and there is an information "firewall" that NP can legally "hide behind" because he doesn't have access to the data.

3) They are pushing the legal limits of when to disclose data. (For whatever reason; worst-case would be because we missed the primary end-point and the data is being "milked" as you say).

I am highly confident that they could not withhold disclosure for corporate deals, production, uplisting -- or any other commercial reason.

And I doubt the Feds (via OWS or similar) would want CYDY to violate securities law just to give them more time for an announcement or back room dealings.

My best guess is that it is #2 above and the "new sheriff in town" Dr. MR is making sure the data is as robustly prepared as possible.